Come and join us across the globe
Raul G. Nogueira discusses a major advancement in stroke therapy, focusing on endovascular treatment of large infarcts. He emphasizes the need to rethink our approach to acute stroke decision-making, differentiating between prognosis and treatment benefits. Raul Nogueira argues that measurements of infarct size are imperfect and highlights the importance of considering factors like age, brain frailty, and socio-economic status. He explains that the benefit of reperfusion extends beyond reducing stroke volume, impacting infarct quality and cerebral edema.
This presentation underscores the shift towards precision medicine in stroke treatment.
